Europese Unie - Nederlands - EMA (European Medicines Agency)

virbac s.a. - purified p45 feline leukaemia virus envelope antigen, live feline calicivirus (strain f9), live feline viral rhinotracheitis virus (strain f2), live feline panleucopenia virus - live feline panleucopenia virus / parvovirus + live feline rhinotracheïtis virus + live feline calicivirus + geïnactiveerd feline leukemie virus - cats - voor actieve immunisatie van katten vanaf een leeftijd van acht weken tegen: feline calicivirose om klinische symptomen te verminderen. feliene virale rhinotracheïtis om klinische symptomen en virale uitscheiding te verminderen. katachtige panleucopenie om leukopenie te voorkomen en om klinische symptomen te verminderen. feliene leukemie om persistente viremie en klinische verschijnselen van de gerelateerde ziekte te voorkomen. begin immuniteit: 3 weken na de primaire vaccinatie voor de componenten panleucopenie en leukemie, en 4 weken na de primaire vaccinatie voor de calicivirus- en rhinotracheitis-viruscomponenten. duur van immuniteit: een jaar na de primaire vaccinatie voor alle componenten.

Europese Unie - Nederlands - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains), attenuated chlamydophila felis (905 strain), attenuated feline panleucopenia virus (pli iv) - immunologicals voor felidae, - cats - active immunisation of cats aged eight weeks and older:• against feline viral rhinotracheitis to reduce clinical signs;• against calicivirus infection to reduce clinical signs;• against chlamydophila felis infection to reduce clinical signs;• against feline panleucopenia to prevent mortality and clinical signs. onsets van immuniteit zijn aangetoond een week na de primaire vaccinatiekuur voor rhinotracheitis, calicivirus, chlamydophila felis en panleucopenie componenten. the duration of immunity is one year after the last re-vaccination for the chlamydiosis component, and oneyear after primary vaccination and three years after the last re-vaccination for the rhinotracheitis, calicivirosis and panleucopenia components.

Europese Unie - Nederlands - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains), attenuated feline panleucopenia virus (pli iv), felv recombinant canarypox virus (vcp97) - immunologicals voor felidae, - cats - active immunisation of cats aged 8 weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs ;against feline panleucopenia to prevent mortality and clinical signs;against leukaemia to prevent persistent viraemia and clinical signs of the related disease. onsets of immunity are 1 week after primary vaccination course for rhinotracheitis, calicivirus and panleucopenia components, and 2 weeks after primary vaccination course for feline leukaemia component. the duration of immunity is one year after the last re-vaccination for the feline leukaemia component, and one year after primary vaccination course and three years after the last re-vaccination for the rhinotracheitis, calicivirosis and panleucopenia components.

Europese Unie - Nederlands - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains), attenuated feline panleucopenia virus (pli iv), felv recombinant canarypox virus (vcp97), attenuated chlamydophila felis (905 strain) - immunologicals voor felidae, - cats - active immunisation of cats aged 8 weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs;against chlamydophila felis infection to reduce clinical signs;against feline panleucopenia to prevent mortality and clinical signs;against leukaemia to prevent persistent viraemia and clinical signs of the related disease. onsets of immunity are 1 week after primary vaccination course for rhinotracheitis, calicivirus, chlamydophila felis and panleucopenia components, and 2 weeks after primary vaccination course for feline leukaemia component. the duration of immunity is one year after the last re-vaccination for the chlamydiosis and feline leukaemia components, and one year after primary vaccination course and three years after the last re-vaccination for the rhinotracheitis, calicivirosis and panleucopenia components.

Europese Unie - Nederlands - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains) - immunologicals voor felidae, - cats - active immunisation of cats aged eight weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs. onsets of immunity isone week after primary vaccination course. the duration of immunity is one year after primary vaccination course and three years after the last re-vaccination.

Europese Unie - Nederlands - EMA (European Medicines Agency)

merial - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains), attenuated chlamydophila felis (905 strain) - immunologicals voor felidae, - cats - active immunisation of cats aged 8 weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs and excretion;against chlamydophila felis infection to reduce clinical signs. onsets van immuniteit zijn aangetoond 1 week na de primaire vaccinatiekuur voor rhinotracheitis, calicivirus en chlamydophila felis componenten. de duur van de immuniteit is 1 jaar na de laatste (her) vaccinatie.

Europese Unie - Nederlands - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - attenuated feline panleucopenia virus (pli iv) - immunologicals voor felidae, - cats - active immunisation of cats aged eight weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs;against feline panleucopenia to prevent mortality and clinical signs. onset of immunity is one week after primary vaccination course the duration of immunity is one year after the primary vaccination course and three years after the last re-vaccination.

België - Nederlands - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

eli lilly benelux - chlamydophila feline (= chlamydia psittaci); geïnactiveerd kattenrhinotracheïtisvirus; levend kattenpanleukopenievirus; levend kattencalicivirus - lyofilisaat en oplosmiddel voor oplossing voor injectie - chlamydophila feline (= chlamydia psittaci); geïnactiveerd kattenrhinotracheïtisvirus; levend kattenpanleukopenievirus; levend kattencalicivirus - feline panleucopenia virus / parvovirus + feline rhinotracheitis virus + feline calicivirus + chlamydia - kat

Europese Unie - Nederlands - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - feline leukemie virus recombinant canarypox virus (vcp97) - immunologicals voor felidae, - cats - actieve immunisatie van katten van 8 weken of ouder tegen feliene leukemie voor de preventie van persistente viremie en klinische symptomen van de gerelateerde ziekte. het begin van de immuniteit is aangetoond 2 weken na de primaire vaccinatiekuur. de immuniteitsduur is één jaar na de laatste vaccinatie.

Europese Unie - Nederlands - EMA (European Medicines Agency)

zoetis belgium sa  - inactivated feline rhinotracheitis virus, inactivated feline calicivirus, inactivated feline chlamydophila felis, inactivated feline leukaemia virus, inactivated feline panleukopenia virus - immunologische - cats - voor de actieve immunisatie van gezonde katten negen weken of ouder tegen feline panleukopenia en feline leukemie virussen en tegen aandoeningen van de luchtwegen, veroorzaakt door het feline rhinotracheïtis virus, feline calicivirus en chlamydophila felis.